biOasis Technologies Inc. announced the appointment of Christopher P. Lowe, M.B.A., as chief financial officer and board advisor. Lowe will report to Mark Day, Ph.D., president and chief executive officer of biOasis and will be responsible for the company's corporate and financial strategy, including transactions and fundraising. Christopher P. Lowe, M.B.A., has over 15 years of senior management experience as president, chief business officer and chief financial officer (CFO) of various private and public life sciences, medical technology and technology companies. Since January 2014, Mr. Lowe has been a partner at FLG Partners, where he also sits on FLG's Management Committee.

He served as an interim CEO of Hansen Medical, Inc., from February 2014 to May 23, 2014. He served as an interim CFO and principal accounting officer of Hansen Medical Inc., from June 10, 2014 to July 27, 2016.